More Irbesartan Tablet Recalls Issued Over NDEA Contamination
Eight lots of irbesartan and irbesartan HCTZ are being recalled due to the presence of cancer-causing impurities.
Eight lots of irbesartan and irbesartan HCTZ are being recalled due to the presence of cancer-causing impurities.
A valsartan class action lawsuit accuses drug makers of fraud for selling contaminated hypertension drugs for years that could put consumers at an increased risk of cancer.